Equities

Anpario PLC

ANP:LSE

Anpario PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)255.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.63k
  • 1 Year change-2.86%
  • Beta1.0174
Data delayed at least 20 minutes, as of Apr 26 2024 16:29 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, April 26, 2024Fri, Apr 26, 2024255.00260.00254.55255.0010,62810.63k
Thursday, April 25, 2024Thu, Apr 25, 2024255.00259.00253.55255.0021,01721.02k
Wednesday, April 24, 2024Wed, Apr 24, 2024250.00259.00250.16255.0019,46819.47k
Tuesday, April 23, 2024Tue, Apr 23, 2024250.00254.90249.26250.0016,33616.34k
Monday, April 22, 2024Mon, Apr 22, 2024250.00253.70249.00250.0016,16816.17k
Friday, April 19, 2024Fri, Apr 19, 2024250.00254.90251.50250.002,0082.01k
Thursday, April 18, 2024Thu, Apr 18, 2024250.00254.90249.00250.005,2865.29k
Wednesday, April 17, 2024Wed, Apr 17, 2024250.00254.90245.10250.006,7166.72k
Tuesday, April 16, 2024Tue, Apr 16, 2024245.00254.00248.90250.008,5268.53k
Monday, April 15, 2024Mon, Apr 15, 2024245.00250.00246.19245.0014,77914.78k
Friday, April 12, 2024Fri, Apr 12, 2024245.00250.00240.00245.0018,21618.22k
Thursday, April 11, 2024Thu, Apr 11, 2024245.00247.50240.00245.0026,57826.58k
Wednesday, April 10, 2024Wed, Apr 10, 2024250.00249.00240.00245.0027,13027.13k
Tuesday, April 09, 2024Tue, Apr 09, 2024232.50250.00229.50250.0066,36366.36k
Monday, April 08, 2024Mon, Apr 08, 2024235.00237.62233.00232.5031,97531.98k
Friday, April 05, 2024Fri, Apr 05, 2024232.50240.00231.00235.0024,72824.73k
Thursday, April 04, 2024Thu, Apr 04, 2024235.00240.00230.00235.0033,39333.39k
Wednesday, April 03, 2024Wed, Apr 03, 2024232.50240.00230.00235.0064,83864.84k
Tuesday, April 02, 2024Tue, Apr 02, 2024230.00235.00225.00232.5097,98997.99k
Data delayed at least 20 minutes, as of Apr 26 2024 17:29 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.